Recent studies have shown promising results in using FMT to improve immune checkpoint inhibitors, a class of drugs used in cancer immunotherapy. Some patients who initially did not respond to these treatments have shown improved outcomes after undergoing FMT. This suggests that modifying the gut microbiome could potentially overcome resistance to certain cancer therapies.
